The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Regulatory News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Collagen Solutions Acquired by Rosen’s Diversified

20 Oct 2020 07:03

RNS Number : 5425C
Collagen Solutions PLC
20 October 2020
 

 

 

20 October 2020

 

Collagen Solutions plc

("Collagen Solutions" or the "Company")

 

Collagen Solutions Plc Acquired by Rosen's Diversified, Inc.

 

Collagen Solutions Plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that today Rosen's Diversified, Inc. ("RDI") declared that its offer to acquire Collagen Solutions plc (the "Offer") had become wholly unconditional and as a result, Collagen Solutions will become part of the RDI Group.

 

RDI is a multi-billion dollar, family-owned and controlled business, headquartered in Minnesota near the Company's U.S. offices. RDI sells a broad range of food, agricultural and scientific products into more than 30 countries, across five continents, and has over 4,500 employees. Collagen Solutions will become part of RDI's life sciences division, which includes Scientific Life Solutions ("SLS"), a supplier of critical components to the bioresearch and biomedical fields.

 

Jamal Rushdy, CEO of Collagen Solutions said: "We have made tremendous progress in our vision to be the industry's first choice for regenerative biomaterials. We believe that being part of RDI will generate significant growth opportunities and create enhanced value for the benefit of all stakeholders and in particular our employees, customers and suppliers. I am optimistic and excited for the potential for continued momentum and greater opportunity for Collagen Solutions." 

 

Wade Rosen, Director of RDI and Executive Vice President of Corporate Development of SLS said: "Collagen Solutions represents an attractive strategic and cultural fit with SLS and we have been highly impressed by the long-term vision and ethos of the Company. The successful completion of the Offer will now provide a foundation for SLS to become a major tissue provider in North America, leveraging the RDI Group's local porcine and bovine harvest, logistics and distribution capabilities in the United States. Collagen's international presence will also provide a platform for SLS to extend its supply of porcine and bovine tissue into the EMEA and APAC regions."

 

England & Company, LLC and Goodbody Stockbrokers UC acted, in relation to the Offer, as joint financial advisers to Collagen Solutions. Shepherd and Wedderburn LLP acted as legal adviser to Collagen Solutions.

 

Strand Hanson and Faegre Drinker acted, in relation to the Offer, as sole financial adviser and legal adviser to RDI, respectively.

 

Enquiries:

Collagen Solutions PlcJamal Rushdy, CEOHilary Spence, CFO

via Walbrook

England & Company LLC(Joint Financial Adviser to Collagen Solutions Plc)Craig EnglandPaul Teitelbaum

Tel: +1 (212) 235-0850

Goodbody Stockbrokers UC(Rule 3 Adviser and Joint Financial Adviser to Collagen Solutions Plc)Stephen KaneChristopher McAuliffe

Tel: +353 (0) 1 667 0400

Cenkos Securities plc(Nominated Adviser and Broker to Collagen Solutions Plc)Giles BallenyMax Gould

Tel: +44 (0) 207 397 8900

Walbrook PR Ltd(Financial PR adviser to Collagen Solutions Plc)Anna Dunphy

Tel: +44 (0) 207 933 8780or collagen@walbrookpr.com

Mob: +44 (0) 7876 741 001

Rosen's Diversified, Inc.David Krawitz, Director of Strategy, Operations and Sales

Tel: +1 (612) 406-5181

Strand Hanson Limited(Financial Adviser to Rosen's Diversified, Inc.)Stuart FaulknerMatthew ChandlerJames DanceJack Botros

Tel: +44 (0) 207 409 3494

Important Notice

England & Company LLC, through its wholly owned subsidiary, England Securities, LLC, is acting as joint financial adviser to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of England & Company LLC nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither England & Company LLC nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of England & Company LLC in connection with this announcement, any statement contained herein or otherwise.

Goodbody Stockbrokers UC, trading as Goodbody, which is regulated in Ireland by the Central Bank of Ireland and in the UK by the Financial Conduct Authority, is acting as sole Rule 3 adviser and joint financial adviser to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of Goodbody Stockbrokers UC nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither Goodbody Stockbrokers UC nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Goodbody Stockbrokers UC in connection with this announcement, any statement contained herein or otherwise.

Cenkos Securities plc, which is authorised and regulated in the United Kingdom by the Financial Conduct Authority, is acting exclusively as nominated adviser and broker to Collagen and no-one else in connection with the Offer and other matters described in this announcement and will not be responsible to anyone other than Collagen for providing the protections afforded to clients of Cenkos Securities plc nor for providing advice in relation to the Offer, the contents of this announcement or any other matter referred to herein. Neither Cenkos Securities plc nor any of its subsidiaries, branches or affiliates owes or accepts any duty, liability or responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person who is not a client of Cenkos Securities plc in connection with this announcement, any statement contained herein or otherwise.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
ACQDGBDGLXBDGGC
Date   Source Headline
29th Apr 20208:28 amRNSForm 8.5 (EPT/NON-RI)
28th Apr 20204:25 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 20204:22 pmRNSForm 8 (OPD) - Collagen Solutions plc
27th Apr 20202:58 pmRNSForm 8.3 - Collagen Solutions plc
27th Apr 202011:05 amRNSForm 8.3 - Collagen Solutions plc
24th Apr 20202:51 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20202:45 pmRNSForm 8.3
24th Apr 202012:21 pmRNSForm 8.3 - Collagen Solutions Plc
24th Apr 20209:40 amRNSForm 8.5 (EPT/NON-RI)
24th Apr 20207:00 amRNSDirector/PDMR Shareholding
23rd Apr 202012:10 pmGNWForm 8.3 - Collagen Solutions Plc
23rd Apr 20207:00 amRNSTrading update
22nd Apr 20201:30 pmRNSForm 8.3 - Collagen Solutions plc
22nd Apr 20209:27 amRNSForm 8.5 (EPT/NON-RI)
21st Apr 20209:31 amRNSForm 8.5 (EPT/NON-RI)
20th Apr 20208:21 amRNSForm 8.5 (EPT/NON-RI)
17th Apr 20202:33 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 202012:35 pmRNSForm 8.3 - Collagen Solutions plc
17th Apr 20208:35 amRNSForm 8.5 (EPT/NON-RI)
16th Apr 20207:00 amRNSStrategic Review and Formal Sale Process
18th Mar 20207:00 amRNSTrading update
3rd Dec 20197:00 amRNSHalf-year Report
19th Nov 20197:00 amRNSInvestor results presentation
13th Nov 20197:00 amRNSDirectorate Change
22nd Oct 20197:00 amRNSTrading Update & Notice of Results
3rd Oct 20197:00 amRNSDirector/PDMR Shareholding
29th Aug 20197:00 amRNSInvestor presentation
28th Aug 201911:29 amRNSResult of AGM
28th Aug 20197:00 amRNSAGM Statement
8th Aug 201910:53 amRNSDirector/PDMR Shareholding
24th Jul 20197:00 amRNSPosting of Annual Report and Notice of AGM
11th Jul 20197:00 amRNSDirector/PDMR Shareholding
9th Jul 201912:18 pmRNSHolding(s) in Company
9th Jul 20197:00 amRNSFinal Results
9th Jul 20197:00 amRNSDirectorate Change
13th Jun 20192:22 pmRNSNotice of Results
10th Jun 20195:13 pmRNSHolding(s) in Company
10th Jun 20195:09 pmRNSHolding(s) in Company
7th Jun 20199:38 amRNSHolding(s) in Company
6th Jun 20192:27 pmRNSHolding(s) in Company
6th Jun 201912:35 pmRNSHolding(s) in Company
6th Jun 20199:52 amRNSDirector/PDMR Shareholding
6th Jun 20197:00 amRNSAppointment of Non-Executive Director
5th Jun 201911:50 amRNSResult of General Meeting and Open Offer
23rd May 20197:00 amRNSInvestor presentation
20th May 20197:00 amRNSStrategic Investment, Placing and Open Offer
9th Apr 20198:08 amEQSCollagen Solutions's losses narrow on improved top line performance
9th Apr 20197:00 amRNSTrading Update
21st Mar 201911:36 amRNSHolding(s) in Company
21st Feb 20192:49 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.